These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 7637098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL.
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM, Nakagawa Y, Coe FL.
    Miner Electrolyte Metab; 1987 Sep; 13(4):267-72. PubMed ID: 3306319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Surface phase transition of hydrated calcium oxalate crystal in the presence of normal and stone-formers' urine.
    Akbarieh M, Tawashi R.
    Scanning Microsc; 1990 Jun; 4(2):387-93; discussion 393-4. PubMed ID: 2402611
    [Abstract] [Full Text] [Related]

  • 8. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N, Hergarten S, Hoppe B, Schmidt M, Hesse A.
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H, Tiselius HG.
    Urol Res; 1997 Jul; 25(5):365-72. PubMed ID: 9373919
    [Abstract] [Full Text] [Related]

  • 10. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ, Coe FL.
    Scand J Urol Nephrol Suppl; 1980 Jul; 53():171-7. PubMed ID: 6937993
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
    Mossetti G, Rendina D, Viceconti R, Manno G, Guadagno V, Strazzullo P, Nunziata V.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.